Trial intelligence / Profile preview

Diclofenac versus acetaminophen suppositories for prevention of ERCP complications in patients with gallstones

IRCT2014020616504N1Phase 2Completed

Sponsor
Vice Chancellor for Research of Mashhad University of Medical Sciences
Start
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of diclofenac and acetaminophen in cholelithiasis (2 arms), sponsored by Vice Chancellor for Research of Mashhad University of Medical Sciences. Primary endpoint: ERCP complications. Started Jan 2014; status: completed.

02

Drugs

diclofenacacetaminophen
03

Conditions

cholelithiasis

Beyond the preview

Go deeper on IRCT2014020616504N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014020616504N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call